• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SYNCARDIA SYSTEMS, LLC SYNCARDIA 70CC TEMPORARY TOTAL ARTIFICIAL HEART (TAH-T); BIVENTRICULAR REPLACEMENT DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SYNCARDIA SYSTEMS, LLC SYNCARDIA 70CC TEMPORARY TOTAL ARTIFICIAL HEART (TAH-T); BIVENTRICULAR REPLACEMENT DEVICE Back to Search Results
Model Number 500101-001
Device Problems Restricted Flow rate (1248); Device Operates Differently Than Expected (2913); Material Integrity Problem (2978)
Patient Problems High Blood Pressure/ Hypertension (1908); Pulmonary Dysfunction (2019); Patient Problem/Medical Problem (2688)
Event Date 12/30/2017
Event Type  Injury  
Manufacturer Narrative
The explanted right ventricle of the tah-t will be returned to syncardia for evaluation.The results of the investigation will be provided in a follow-up mdr.(b)(4) initial.
 
Event Description
The customer, a syncardia certified hospital, reported that the patient was having episodes of very high pulmonary resistance and high central venous pressure, however, the lungs did not appear to be congested.The customer also reported that companion 2 driver settings were maximized and the waveforms on the driver indicated that the tah-t did not appear to be fully ejecting.The customer also reported that a fluoroscopy revealed that something could have been impinging on the right outflow valve.The customer also reported that the right ventricle of the tah-t was explanted and replaced.The customer also reported that the patient was stable and doing well with the replaced right ventricle.
 
Manufacturer Narrative
The following sentence was incorrectly stated in the follow-up report 1: the blood diaphragm (bd) was visually inspected and revealed multiple torn layers of the bd interfering with the movement of the outflow valve.The corrected sentence is as follows: the blood diaphragm (bd) was visually inspected and revealed a tear which interfered with the movement of the outflow valve.
 
Manufacturer Narrative
The 70cc tah-t l/n 099394 right ventricle id: 096619r1114 was returned to syncardia for evaluation.An explant analysis was performed to evaluate the integrity and function of the diaphragm, as well as the functionality of the valves.Visual inspection of the outside of the tah-t found no anomalies or defects.The valve inspection evaluates natural movement to determine if any defects may have been present, preventing them from moving freely as intended.Upon functional evaluation, it was noted that there was obstruction of the outflow valve from within the ventricle, causing the valve disc to not be able to move naturally, thus confirming the customer-reported issue.The blood diaphragm (bd) was visually inspected and revealed multiple torn layers of the bd interfering with the movement of the outflow valve.The ventricle was sent for evaluation by a contract laboratory that had previously conducted tah-t diaphragm analyses.The report from the contract laboratory concluded that the root cause of the bd failure was thinning of the blood diaphragm likely attributable to contact abrasion between the bd and first intermediate diaphragm.There was no evidence of defect in the tah-t ventricle materials or in ventricle construction.Syncardia has a corrective and preventive action (capa) to identify appropriate actions to prevent contact abrasion excess wear.The customer reported to syncardia that the patient subsequently expired on (b)(6) 2018 (tah-t l/n 107141; mfr.Report 3003761017-2018-00213) and listed the device malfuntion of the previously implanted right ventricle of the tah-t (l/n 099394) as a contributing cause to the patient's multi-organ failure, which was listed as the patient's cause of death.Syncardia has completed its evaluation of this complaint and is closing this file.(b)(4) follow-up report 1.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCARDIA 70CC TEMPORARY TOTAL ARTIFICIAL HEART (TAH-T)
Type of Device
BIVENTRICULAR REPLACEMENT DEVICE
Manufacturer (Section D)
SYNCARDIA SYSTEMS, LLC
1992 e. silverlake road
tucson AZ 85713
MDR Report Key7167770
MDR Text Key96495573
Report Number3003761017-2018-00011
Device Sequence Number1
Product Code LOZ
UDI-Device Identifier00858000003008
UDI-Public(01)00858000003008
Combination Product (y/n)N
PMA/PMN Number
P030011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Remedial Action Replace
Type of Report Initial,Followup,Followup
Report Date 11/26/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/05/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2018
Device Model Number500101-001
Device Catalogue Number500101
Device Lot Number099394
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/11/2018
Was the Report Sent to FDA? No
Date Manufacturer Received12/30/2017
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age25 YR
-
-